Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - Expert Opinion on Emerging Drugs, 2019 - Taylor & Francis
ABSTRACT Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune systemic
disease characterized by a complex and not yet completely elucidated etiopathogenesis …
被引用次数：26 相关文章

[引用][C] Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - 2019 - ricerca.unityfvg.it

[引用][C] Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - EXPERT OPINION ON EMERGING DRUGS, 2019 - air.uniud.it
Emerging drugs for primary Sjögren’s syndrome IRIS IRIS Home Sfoglia Macrotipologie &
tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo …

Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - Expert opinion on emerging drugs, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune systemic disease
characterized by a complex and not yet completely elucidated etiopathogenesis, where …

Emerging drugs for primary Sjögren's syndrome.

S Gandolfo, S De Vita - Expert Opinion on Emerging Drugs, 2019 - europepmc.org
Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune systemic disease
characterized by a complex and not yet completely elucidated etiopathogenesis, where …

[引用][C] Emerging drugs for primary Sjögren's syndrome

S Gandolfo, S De Vita - 2019 - ricerca.unityfvg.it